Loading
Latest filing published 02 Oct 2026 for InnoCare Pharma Ltd., €7.8M.
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This profile gathers the share dealings of Cui Jisong in InnoCare Pharma Ltd. We count 20 filings; the first trade dates from 3 June 2020 and the latest from 30 September 2026.
In open-market terms, that means 9 purchases on one side and 6 sales worth €8.4M on the other. No amount is published for 13 filings, which the totals therefore leave out. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Since January 2026: 4 purchases and 2 sales on the market.
The 4 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The newest entry dates from 2 October 2026: an open-market sale of €7.8M, in InnoCare Pharma Ltd. The most recent open-market purchase was published on 23 June 2026, 124 days ago. The median gap between a trade and its publication by HKEX is 2 days. Until a filing is published, the market cannot know about the trade. Every figure here comes from the filings published by HKEX and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations